Mexico Pegylated Proteins Market Size & Outlook, 2022-2030

The pegylated proteins market in Mexico is expected to reach a projected revenue of US$ 55.7 million by 2030. A compound annual growth rate of 10.5% is expected of Mexico pegylated proteins market from 2023 to 2030.

Revenue, 2022 (US$M)
$25.0
Forecast, 2030 (US$M)
$55.7
CAGR, 2023 - 2030
10.5%
Report Coverage
Mexico

Mexico pegylated proteins market highlights

  • The Mexico pegylated proteins market generated a revenue of USD 25.0 million in 2022 and is expected to reach USD 55.7 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 10.5% from 2023 to 2030.
  • In terms of segment, consumables was the largest revenue generating product in 2022.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.

Pegylated proteins market data book summary

Market revenue in 2022USD 25.0 million
Market revenue in 2030USD 55.7 million
Growth rate10.5% (CAGR from 2022 to 2030)
Largest segmentConsumables
Fastest growing segmentServices
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationConsumables, Services
Key market players worldwideThermo Fisher Scientific Inc, Abcam PLC, Enzon Pharmaceuticals Inc, Merck KGaA, Caribou Biosciences Inc Ordinary Shares, NOF Corp, Caleres Inc, Creative PEGWorks, Aurigene Pharmaceutical Services, Laysan Bio

Other key industry trends

  • In terms of revenue, Mexico accounted for 2.0% of the global pegylated proteins market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil pegylated proteins market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 110.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

PEGylated Proteins Market Companies

Name Profile # Employees HQ Website

Mexico pegylated proteins market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pegylated proteins market will help companies and investors design strategic landscapes.


Consumables was the largest segment with a revenue share of 60% in 2022. Horizon Databook has segmented the Mexico pegylated proteins market based on consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.


  • Mexico PEGylated Proteins Product Outlook (Revenue, USD Million, 2018-2030)
    • Consumables
    • Services
  • Mexico PEGylated Proteins Protein Type Outlook (Revenue, USD Million, 2018-2030)
    • Colony-stimulating factor
    • Interferons
    • Erythropoietin
    • Recombinant factor VII
    • Other
  • Mexico PEGylated Proteins End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations
    • Academic Research Institutes
  • Mexico PEGylated Proteins Application Outlook (Revenue, USD Million, 2018-2030)
    • Cancer
    • Autoimmune Disease
    • Hepatitis
    • Multiple Sclerosis
    • Hemophilia
    • Gastrointestinal Disorder
    • Others

Reasons to subscribe to Mexico pegylated proteins market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico pegylated proteins market databook

  • Our clientele includes a mix of pegylated proteins market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico pegylated proteins market , including forecasts for subscribers. This country databook contains high-level insights into Mexico pegylated proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico pegylated proteins market size, by product, 2018-2030 (US$M)

Mexico PEGylated Proteins Market Outlook Share, 2022 & 2030 (US$M)

Mexico pegylated proteins market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more